During the past decade, Ningbo Kangning Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ningbo Kangning Hospital" are "Schizophrenia" (2 trials) and "Insomnia Disorder" (1 trials). Many other conditions were trialed in "Ningbo Kangning Hospital" in a lesser frequency.

Most popular intervention types in "Ningbo Kangning Hospital" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BI 425809" (1 trials), "Iclepertin" (1 trials), "YZJ-1139 20mg" (1 trials) and "YZJ-1139 40mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ningbo Kangning Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ningbo Kangning Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ningbo Kangning Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ningbo Kangning Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".